{"id":"W4391165127","doi":"10.1093/ecco-jcc/jjad212.0035","title":"OP35 Efficacy of mirikizumab in comparison to ustekinumab in patients with moderate to severe Crohn’s disease: Results from the phase 3 VIVID 1 study","year":2024,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Hospital; Western University","funders":"","keywords":"Ustekinumab; Crohn's disease; Medicine; Internal medicine; Disease; Crohn disease; Gastroenterology; Adalimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001663041,0.0006799317,0.001909568,0.0002025452,0.0002086076,0.0007736536,0.0004314009,0.0006212235,0.002547067],"category_scores_gemma":[0.0009712383,0.0002919028,0.001514539,0.0002399599,0.0004595128,0.0005848224,0.0003462746,0.001734591,0.0003553881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004254084,"about_ca_system_score_gemma":0.0006678244,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005041766,"about_ca_topic_score_gemma":0.001182638,"domain_scores_codex":[0.9994426,0.0003271865,0.00003868677,0.00006718807,0.0000553461,0.00006883146],"domain_scores_gemma":[0.9993755,0.0001578708,0.0001656278,0.00003457783,0.00003347086,0.0002329701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8723409,0.008530755,0.004775019,0.001422714,0.002024875,0.00009237554,0.000152595,0.0007486605,0.03292871,0.0001589138,0.001623956,0.07520055],"study_design_scores_gemma":[0.4779462,0.4611578,0.04653351,0.0001533055,0.002818607,0.0003192301,0.0001027465,0.001063535,0.004832057,0.0003472455,0.004674423,0.00005139853],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9797667,0.01673664,0.0003559488,0.0004456851,0.0001177814,0.0005041996,0.0007046983,0.00005691496,0.001311385],"genre_scores_gemma":[0.9943883,0.002749733,0.0005592865,0.0004138608,0.0001389635,0.0003400992,0.000763702,0.000009362536,0.0006366685],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002547067,"threshold_uncertainty_score":0.008795142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0100546497393841,"score_gpt":0.2759954535183122,"score_spread":0.2659408037789281,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}